Published guidance, NICE advice and quality standards | Guidance

Showing 651 to 660 of 851

Sort by

Published guidance, NICE advice and quality standards
Title	Reference number	Published	Last updated
Trametinib in combination with dabrafenib for treating unresectable or metastatic melanoma	TA396	22 June 2016	22 June 2016
Canagliflozin, dapagliflozin and empagliflozin as monotherapies for treating type 2 diabetes	TA390	25 May 2016	25 May 2016
Sacubitril valsartan for treating symptomatic chronic heart failure with reduced ejection fraction	TA388	27 April 2016	27 April 2016
Topotecan, pegylated liposomal doxorubicin hydrochloride, paclitaxel, trabectedin and gemcitabine for treating recurrent ovarian cancer	TA389	27 April 2016	27 April 2016
Ruxolitinib for treating disease-related splenomegaly or symptoms in adults with myelofibrosis	TA386	23 March 2016	23 March 2016
Guidance on the use of temozolomide for the treatment of recurrent malignant glioma (brain cancer)	TA23	26 April 2001	3 March 2016
Ezetimibe for treating primary heterozygous-familial and non-familial hypercholesterolaemia	TA385	24 February 2016	24 February 2016
Nivolumab for treating advanced (unresectable or metastatic) melanoma	TA384	18 February 2016	18 February 2016
TNF-alpha inhibitors for ankylosing spondylitis and non-radiographic axial spondyloarthritis	TA383	1 February 2016	1 February 2016
Enzalutamide for treating metastatic hormone-relapsed prostate cancer before chemotherapy is indicated	TA377	27 January 2016	27 January 2016